Cerebellar Dysfunction in an Elderly Male After a Brief Course of Metronidazole
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
BACKGROUND: Metronidazole, a widely used antibacterial and antiprotozoal drug, is often the drug of choice in amoebic liver abscess. The drug, otherwise safe, can cause serious central nervous disturbances in rare circumstances.
CASE REPORT: Here, we report a case of cerebellar dysfunction in the form of slurring of speech and episodes of falls, in an elderly male following a three-week course of metronidazole therapy.
RESULTS AND CONCLUSION: The patient manifested classic radiologic features of metronidazole neurotoxicity. Marked improvement in clinical symptoms was seen following drug discontinuation.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
Current drug safety - 14(2019), 2 vom: 22., Seite 163-166 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kaur, Upinder [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
140QMO216E |
|---|
| Anmerkungen: |
Date Completed 09.12.2019 Date Revised 17.12.2019 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.2174/1574886314666190206154735 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM293540128 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM293540128 | ||
| 003 | DE-627 | ||
| 005 | 20231225075534.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/1574886314666190206154735 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0978.xml |
| 035 | |a (DE-627)NLM293540128 | ||
| 035 | |a (NLM)30727914 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kaur, Upinder |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cerebellar Dysfunction in an Elderly Male After a Brief Course of Metronidazole |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.12.2019 | ||
| 500 | |a Date Revised 17.12.2019 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
| 520 | |a BACKGROUND: Metronidazole, a widely used antibacterial and antiprotozoal drug, is often the drug of choice in amoebic liver abscess. The drug, otherwise safe, can cause serious central nervous disturbances in rare circumstances | ||
| 520 | |a CASE REPORT: Here, we report a case of cerebellar dysfunction in the form of slurring of speech and episodes of falls, in an elderly male following a three-week course of metronidazole therapy | ||
| 520 | |a RESULTS AND CONCLUSION: The patient manifested classic radiologic features of metronidazole neurotoxicity. Marked improvement in clinical symptoms was seen following drug discontinuation | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a CSF | |
| 650 | 4 | |a Nitro imidazole | |
| 650 | 4 | |a amoebiasis | |
| 650 | 4 | |a neurotoxicity | |
| 650 | 4 | |a pharmacogenetics | |
| 650 | 4 | |a pharmacovigilance. | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 650 | 7 | |a Metronidazole |2 NLM | |
| 650 | 7 | |a 140QMO216E |2 NLM | |
| 700 | 1 | |a Kumar, Ishan |e verfasserin |4 aut | |
| 700 | 1 | |a Singh, Anup |e verfasserin |4 aut | |
| 700 | 1 | |a Kumar, Mukesh |e verfasserin |4 aut | |
| 700 | 1 | |a Chakrabarti, Sankha Shubhra |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current drug safety |d 2006 |g 14(2019), 2 vom: 22., Seite 163-166 |w (DE-627)NLM181475790 |x 2212-3911 |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2019 |g number:2 |g day:22 |g pages:163-166 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/1574886314666190206154735 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 14 |j 2019 |e 2 |b 22 |h 163-166 | ||